SSCA
LLY icon

South Shore Capital Advisors’s Eli Lilly LLY Stock Holding History

South Shore Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Buy
364
+174
+92% +$176K 0.24% 91
2025
Q4 		$204K Buy
+190
New +$182K 0.15% 130

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

South Shore Capital Advisors's LLY Position: Q1 2026 in Review

South Shore Capital Advisors increased its Eli Lilly (LLY) stake by 92% in Q1 2026, buying an estimated $176K and bringing the position to 364 shares worth $334K. The position accounts for 0.24% of the portfolio, ranked #91.

South Shore Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • South Shore Capital Advisors held 364 shares of Eli Lilly worth $334K as of Q1 2026.
  • South Shore Capital Advisors bought 174 Eli Lilly shares in Q1 2026, an estimated $176K.
  • Eli Lilly made up 0.24% of South Shore Capital Advisors's portfolio in Q1 2026, its #91 holding.
  • South Shore Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on South Shore Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.